• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 10/21/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Immune Thereapeutics

  • 9:32 AM

    ORLANDO, Fla., March 17, 2017, IMUN, (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using Lodonal™, its proprietary formulation of lower-dose naltrexone, announced today that the Dominican Republic Ministry of Public Health has granted Immune’s request to export Lodonal to Kenya. Immune Therapeutics formulates and manufactures Lodonal in the Dominican Republic. Local laws require a Certificate of Pharmaceutical Product (“COPP”) to export Lodonal to Kenya. “The granting of our export

    Read more
  • 3:15 PM

    Mart Resources (PublicWire.com Press Release) — AUSTIN, TX, Nov 21, 2013 (Marketwired via COMTEX) — EPIC Corporation (PINKSHEETS: EPOR) (“EPIC”), and Ronald S. Tucker, EPIC’s president, announced, “EPIC’s in progress reorganization and structure and financial restructuring is shareholder motivated. EPIC’s motivation is to demonstrate the company’s true value to investors, which management believes to be $1.70 at the low end and $2.86 per share on the high end based on shares outstanding of 10,669,294. In furtherance of EPIC’s efforts to

    Read more
Public Wire Banner